These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 16209897)
1. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice. Inoue J; Yotsumoto S; Sakamoto T; Tsuchiya S; Aramaki Y J Control Release; 2005 Nov; 108(2-3):294-305. PubMed ID: 16209897 [TBL] [Abstract][Full Text] [Related]
2. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in NC/Nga mice. Inoue J; Yotsumoto S; Sakamoto T; Tsuchiya S; Aramaki Y Pharm Res; 2005 Oct; 22(10):1627-33. PubMed ID: 16180119 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN. Vasilakos JP; Smith RM; Gibson SJ; Lindh JM; Pederson LK; Reiter MJ; Smith MH; Tomai MA Cell Immunol; 2000 Aug; 204(1):64-74. PubMed ID: 11006019 [TBL] [Abstract][Full Text] [Related]
4. Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN. Kim YS; Kim Y; Lee KJ; Kwon HJ; Kim DS; Kim TY Int Arch Allergy Immunol; 2007; 144(4):315-24. PubMed ID: 17671391 [TBL] [Abstract][Full Text] [Related]
5. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway. Xu W; Tamura T; Takatsu K Int Immunopharmacol; 2008 Feb; 8(2):351-61. PubMed ID: 18182251 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides. Inoue J; Aramaki Y Vaccine; 2007 Jan; 25(6):1007-13. PubMed ID: 17049678 [TBL] [Abstract][Full Text] [Related]
7. Changes in immune responses to mite antigen sensitized through barrier-disrupted skin with CpG-oligodeoxynucleotide in mice. Inoue J; Yotsumoto S; Sakamoto T; Tsuchiya S; Aramaki Y Biol Pharm Bull; 2006 Feb; 29(2):385-7. PubMed ID: 16462052 [TBL] [Abstract][Full Text] [Related]
8. The complement component C3 plays a critical role in both Th1 and Th2 responses to antigen. Yalcindag A; He R; Laouini D; Alenius H; Carroll M; Oettgen HC; Geha RS J Allergy Clin Immunol; 2006 Jun; 117(6):1455-61. PubMed ID: 16751013 [TBL] [Abstract][Full Text] [Related]
10. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine. Nakagome K; Okunishi K; Imamura M; Harada H; Matsumoto T; Tanaka R; Miyazaki J; Yamamoto K; Dohi M J Immunol; 2009 Jul; 183(1):209-20. PubMed ID: 19542432 [TBL] [Abstract][Full Text] [Related]
11. Immunostimulatory sequence CpG elicits Th1-type immune responses in inflammatory skin lesions in an atopic dermatitis murine model. Wang G; Fyhrquist-Vanni N; Wolff H; Dieu-Nosjean MC; Kemeny L; Homey B; Lauerma AI; Alenius H Int Arch Allergy Immunol; 2008; 147(1):41-51. PubMed ID: 18446052 [TBL] [Abstract][Full Text] [Related]
12. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice. Zhu FG; Kandimalla ER; Yu D; Tang JX; Agrawal S Int Immunopharmacol; 2004 Jul; 4(7):851-62. PubMed ID: 15182725 [TBL] [Abstract][Full Text] [Related]
13. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081 [TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen. Tewary P; Sukumaran B; Saxena S; Madhubala R Vaccine; 2004 Aug; 22(23-24):3053-60. PubMed ID: 15297055 [TBL] [Abstract][Full Text] [Related]
15. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine. Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis. Amaral CC; Garcia IP; Fernandes GF; Almeida SR; Camargo ZP; Souza MC Scand J Immunol; 2005 Oct; 62(4):325-33. PubMed ID: 16253119 [TBL] [Abstract][Full Text] [Related]
17. Co-administration of CpG oligonucleotides and chenopodium album extract reverse IgG2a/IgG1 ratios and increase IFN-gamma and IL-10 productions in a murine model of asthma. Mousavi T; Salek Moghadam A; Falak R; Tebyanian M Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):1-6. PubMed ID: 18322305 [TBL] [Abstract][Full Text] [Related]
18. Suppression of Th1 and Th2 immune responses in mice by Sinomenine, an alkaloid extracted from the chinese medicinal plant Sinomenium acutum. Feng H; Yamaki K; Takano H; Inoue K; Yanagisawa R; Yoshino S Planta Med; 2006 Dec; 72(15):1383-8. PubMed ID: 17091433 [TBL] [Abstract][Full Text] [Related]
19. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung. Ashino S; Wakita D; Zhang Y; Chamoto K; Kitamura H; Nishimura T Int Immunol; 2008 Feb; 20(2):259-66. PubMed ID: 18156622 [TBL] [Abstract][Full Text] [Related]